Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
3.620
+0.360 (11.04%)
At close: May 9, 2025, 4:00 PM
3.460
-0.160 (-4.42%)
After-hours: May 9, 2025, 7:13 PM EDT
Kazia Therapeutics Stock Forecast
KZIA's stock price has decreased by -74.97% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for Kazia Therapeutics stock ranges from a low of $15 to a high of $100. The average price target of $57.5 forecasts a 1,488.40% increase in the stock price over the next year.
Price Target: $57.50 (+1,488.40%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 6, 2025.
Analyst Ratings
The average analyst rating for Kazia Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Maxim Group | Maxim Group | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +314.36% | Feb 6, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +2,662.43% | Jul 12, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $100 | Hold → Strong Buy | Upgrades | $100 | +2,662.43% | Apr 11, 2023 |
Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 2, 2022 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 2, 2022 |
Financial Forecast
Revenue This Year
n/a
from 2.48M
Revenue Next Year
n/a
EPS This Year
-26.52
from -50.78
EPS Next Year
-12.95
from -26.52
Financial currency is AUD. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | n/a | n/a | n/a | ||
Avg | n/a | n/a | n/a | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -27.30 | -13.34 | -10.34 | ||
Avg | -26.52 | -12.95 | -10.05 | ||
Low | -25.48 | -12.45 | -9.65 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.